[1]
Mashhadi, M.A., Sepehri, Z., Bakhshipour, A.R., Zivari, A., Danesh, H.A., Metanat, H.A., Karimkoshteh, A., Hashemi, S.M., Rahimi, H. and Kiani, Z. 2016. Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer. International Journal of Hematology-Oncology and Stem Cell Research. 10, 4 (Oct. 2016), 212-216.